Advertisement

Hematologist-Oncologist - Multiple Myeloma and Plasma Cell Disorders - Kansas City, KS, USA

Job Description

The University of Kansas Cancer Center is seeking a Hematologist/Oncologist with a focus in Multiple Myeloma and Plasma Cell Disorders to join the Division of Hematologic Malignancies and Cellular Therapeutics (HMCT) team. We are the region's largest Blood Cancer and Cellular Immunotherapy program in Kansas.

Qualified candidates must have completed an ACGME accredited Hematology/Oncology fellowship, and be board certified/eligible in Hematology.  

LEADERSHIP opportunities available!

Responsibilities:

  • Provide medical care for both outpatient clinic and hospitalized patients
  • Appointment on clinical scholar track
  • Contribute to various research, educational and clinical initiatives related to areas of individual interest and expertise
  • Advance the science of transplant and cellular therapeutics through participation in research when able, while staying abreast of changes to evidence-based medicine for patients with hematologic malignancies

Organization:

  • The HMCT Division is comprised of leading experts in the treatment of hematologic malignancies and immune deficiencies, with 21 faculty members dedicated to seeking novel approaches to achieve more-effective outcomes while reducing or minimizing the short-and long-term effects of treatment, both in the laboratory and in state-of-the-art clinical facilities.
  • HMCT therapeutics division operates a large, state-of-the-art, outpatient care facility, therapeutic blood treatment/apheresis center, and annually receives >800 referrals a year and annually performs >300 transplants and CAR-T/cell therapy procedures.
  • The HMCT division has a comprehensive portfolio of pharma-sponsored and investigator-initiated BMT and CAR-T and cell therapy clinical trials and is also a certified CAR-T center for Novartis, Kite and BMS.
  • FACT Accredited and Immune Effector Cell (IEC) program that performs autologous and allogenic transplants, CAR T-cell and cellular therapeutics for blood cancers and solid tumors
  • 1,045-bed academic medical center, and 84 bed unit for BMT, cellular therapeutics and hematologic malignancy patients.  The HMCT division received a $66M philanthropic gift that was utilized to construct a state-of-the-art 3-floor inpatient care unit, which is dedicated to patients with hematologic malignancies and solid tumors.
  • 12th consecutive year ranking in US News & World Report's "Best Hospital" designation for Cancer Hospitals
  • NCI designated Cancer Center and CIBMTR BMT CTN affiliate center
  • Official medical provider for the Kansas City Royals and the Kansas City Chiefs
  • Consistently earns national recognition for outstanding quality and safety
  • Magnet designation in nursing achieved yearly since 2006

Kansas City:

  • Bi-state population of greater than 2 million
  • A "hidden gem" winning the award of America's 4th most Cultured City by Travel+Leisure magazine
  • Affordable housing including downtown lofts, suburban neighborhoods, and rural properties
  • A robust arts scene including symphony, ballet, theatre and museums
  • Sports enthusiasts can enjoy a variety of professional and collegiate sports
  • Outdoor activities abound with more than 600 parks and 24 public lakes

Contact Email: Email me more information
Employer: The University of Kansas Hospital
Location: Kansas City, KS, USA
Position Type: Physician (MD, DO, Resident)
Employment Type: Permanent
Specialty: Oncology
Salary Range:

Advertisement